Eisai Co Ltd Spons A (ESALY) 58.5000 $ESALY BioCryst

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Eisai Co Ltd Spons A (ESALY) 58.5000 $ESALY

BioCryst Pharmaceuticals (BCRX) Jumps: Stock Rises 13.7%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:25AM CDT
BioCryst Pharmaceuticals, Inc. (BCRX) moved big last session, as its shares jumped almost 14% on the day.
BCRX: 3.62 (+0.16)

Ardelyx (ARDX) Catches Eye: Stock Moves 14.2% Higher
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 7:25AM CDT
Ardelyx, Inc. (ARDX) moved big last session, as its shares jumped over 14% on the day.
ARDX: 10.68 (+0.06)

Valeant (VRX) Loses European Rights to Psoriasis Candidate
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 9:59AM CDT
Valeant (VRX) announced that its partner AstraZeneca (AZN) has amended the company's license to its pipeline candidate, brodalumab.
VRX: 22.30 (-0.83), UTHR: 121.01 (+2.02), AZN: 34.14 (-0.15)

GlycoMimetics (GLYC) Worth Watching: Stock Surges 13.1%
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:00AM CDT
GlycoMimetics, Inc. (GLYC) was a big mover last session, as the company's shares rose over 13% on the day.
GLYC: 8.35 (-0.12)

Drug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY
Zacks Equity Research - Zacks Investment Research - Wed May 11, 9:03AM CDT
Quite a few companies are still yet to report results. Let's take a peek at a few drug stocks that will report quarterly results later this week
JNJ: 125.23 (+0.77), GILD: 79.47 (-1.77), PFE: 36.89 (+0.22), AMGN: 172.03 (+0.75), ABBV: 66.23 (+1.51), RDY: 43.65 (+0.04), AVXS: 37.63 (+0.13), NVS: 83.26 (+1.18)

Jazz (JAZZ) Q1 Earnings: A Beat in the Cards for the Stock?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 4:13PM CDT
Jazz Pharmaceuticals (JAZZ), which is set to report first-quarter 2016 results on May 10, delivered a positive earnings surprise of 36.75% last quarter.
IPXL: 31.42 (-0.05), CLSN: 1.23 (unch), JAZZ: 150.97 (-1.85)

Halozyme Raises Funds to Support Ongoing Oncology Studies
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 3:55PM CST
Halozyme (HALO) announced that it has entered into a $150 million credit agreement secured by future royalties from Enhanze products, which Halozyme is entitled to receive from its collaborations with Roche and Baxalta, Inc.
HALO: 9.94 (+0.17), BXLT: 46.02 (-0.18)

Arena (ARNA)/Eisai's Belviq XR NDA Accepted for Review
Arpita Dutt - Zacks Investment Research - Tue Dec 01, 3:32PM CST
Arena (ARNA) is looking to get a once-daily formulation of its chronic weight management treatment approved in the U.S.
ACHN: 8.28 (+0.01), BXLT: 46.02 (-0.18), ARNA: 1.67 (-0.01)

Arena 3Q Loss Narrower-Than-Expected, Belviq in Focus
Arpita Dutt - Zacks Investment Research - Wed Nov 11, 9:34AM CST
Arena (ARNA) is looking to cut costs and improve efficiency through a restructuring plan.
ACHN: 8.28 (+0.01), BXLT: 46.02 (-0.18), ARNA: 1.67 (-0.01)

Jazz's Q3 Earnings & Revenues Grow Y/Y; Trims 2015 Outlook
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 8:30AM CST
Jazz Pharmaceuticals (JAZZ) reported third-quarter 2015 adjusted earnings of $2.16 per share, up 7.5% year over year.
JAZZ: 150.97 (-1.85), TEVA: 53.50 (-1.29), CNCE: 11.49 (-0.28)

Corcept's Q2 Loss Narrower than Expected, View Narrowed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 06, 10:35AM CDT
Corcept Therapeutics (CORT) posted loss of a penny per share in the second quarter of 2015, narrower than both the Zacks Consensus Estimate of a loss of 5 cents.
VRX: 22.30 (-0.83), ANAC: 99.06 (-0.14), CORT: 5.80 (-0.06)

Arena Pharmaceuticals 2Q Loss Narrower-Than-Expected - Analyst Blog
Arpita Dutt - Zacks Investment Research - Thu Aug 06, 8:10AM CDT
Although Arena Pharmaceuticals' (ARNA) second quarter loss was narrower-than-expected, revenues missed expectations.
GILD: 79.47 (-1.77), ARNA: 1.67 (-0.01)

Will Epizyme (EPZM) Pull a Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 05, 12:40PM CDT
Epizyme (EPZM) has an Earnings ESP of 3.08% with a Zacks Rank #2 and is scheduled to report its second-quarter 2015 results on Aug 6.
INO: 9.88 (+0.26), EPZM: 10.36 (+0.10), GSK: 45.07 (-0.11)

Will Arena Pharmaceuticals (ARNA) Surprise Q2 Earnings? - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 04, 12:00PM CDT
Investor focus will remain on the performance of Arena's (ARNA) obesity treatment - Belviq.
BDSI: 2.55 (+0.20), VVUS: 1.07 (+0.01), ARNA: 1.67 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 22

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 13

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 9

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 31

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading
Cogent Communications' Q3 2026 Earnings Call Details

Updated Category News Views 12

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Continue Reading
Oracle Announces AI-Driven QuickStart Platform Launch

Updated Category News Views 24

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 22

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 19

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 19

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 19

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Underwater Communication Sector

Updated Category News Views 134

Forecast for the Underwater Communication System Market The underwater communication system market is surging with an expected valuation of USD 9.7 billion by 2032, a significant leap from its valuation of USD 4.2 billion in 2023. This impressive growth is largely attributed to the escalating need for effective underwater communication technologies, driven by factors such...

Continue Reading
US Foods Reveals 2024 Dining Trends Transforming Consumer Choices

Updated Category News Views 592

Exploring New Diner Trends for 2024 US Foods Holding Corp. (NYSE: USFD), a leading name in the foodservice distribution sector, has recently shared intriguing insights from its 2024 Diner Dispatch survey. This comprehensive study delves into the ever-changing landscape of dining out, shedding light on American consumers' preferences and behaviors as they navigate the...

Continue Reading
Invest in Fun: LAVA Island Fund Sparks Amusement Expansion

Updated Category News Views 247

NARRATE launched the LAVA Island Investment Fund back in 2024, targeting accredited investors eager to jump into the indoor amusement park scene. Desks were buzzing with excitement as this initiative promised substantial returns for those willing to dive in. And you know how it goes when something like this hits—the chatter around potential gains or losses lights up the...

Continue Reading
Habanos, S.A. Celebrates Exclusive Ramón Allones Launch Event

Updated Category News Views 275

A Grand Celebration for Ramón Allones Absolutos Edición Limitada 2024 Habanos, S.A., in collaboration with Intertabak AG, recently hosted a spectacular global launch for the Ramón Allones Absolutos Edición Limitada 2024. This prestigious event took place at the elegant "Halle 7," drawing tobacco enthusiasts, retailers, and journalists who share a passion for fine...

Continue Reading
JBG SMITH Prepares to Release Q3 2024 Financial Results

Updated Category News Views 168

JBG SMITH Announces Third Quarter Financial Results JBG SMITH (NYSE: JBGS), a notable owner and developer of premium mixed-use properties, has set a date for announcing its financial results for the third quarter of 2024. This important event is slated to occur after the close of trading on an upcoming date. Investors and stakeholders can anticipate insight into the...

Continue Reading